Enregistrement :
5
de
13
(2019-08-26
à
2020-01-27)
Subvention, Contribution ou autre avantage financier
In the past year, there have been various meetings with Provincial and Federal government to secure funding for expansion. Dollars secured in 2018 are listed within, with expectation to secure significant funding in the 2019 year as a result of these activities.
Source of funds were sought from Canada’s Strategic Innovation Fund (SIF). In March 2019, BioVectra Inc. was granted $38.5M in the form of grants and conditionally repayable loans to expand API and scaled biologics capacity in the Atlantic Region.